ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

BCRX BioCryst Pharmaceuticals Inc

7.69
-0.17 (-2.16%)
After Hours
Last Updated: 21:02:55
Delayed by 15 minutes

BioCryst Pharmaceuticals Financial Summary

The current BCRX market cap is 1.61B. The company's latest EPS is USD -0.4253 and P/E is -18.03.

Quarter End Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024
USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)
Total Revenue 93.4M92.76M109.33M117.09M131.53M
Operating Income -42.67M-14.49M8.76M7.69M-4.51M
Net Income -61.73M-35.38M-12.67M-14.03M-26.8M
Year End 31 December 2024 20202021202220232024
USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)
Total Revenue 17.81M157.17M270.83M331.41M450.71M
Operating Income -174.76M-177.72M-148.44M-103.71M-2.54M
Net Income -182.81M-184.06M-247.12M-226.54M-88.88M
Quarter End Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024
USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)
Total Assets 516.96M467.89M472.42M491.25M490.42M
Total Liabilities 972.49M944.06M948.03M959.82M966.35M
Total Equity -455.53M-476.17M-475.61M-468.56M-475.93M
Year End 31 December 2024 20202021202220232024
USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)
Total Assets 334.72M588.15M550M516.96M490.42M
Total Liabilities 353.98M695.14M844.6M972.49M966.35M
Total Equity -19.26M-106.99M-294.6M-455.53M-475.93M
Quarter End Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024
USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)
Operating -95.14M-53.68M-55.05M-46.81M-52.02M
Investing -131.5M28.76M26.31M34.8M52.59M
Financing 32.49M-1.05M-3.01M-1.74M-5.76M
Year End 31 December 2024 20202021202220232024
USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)
Operating -137.22M-142.16M-161.85M-95.14M-52.02M
Investing -6.86M15.8M-128.24M-131.5M52.59M
Financing 302.7M359.67M88.03M32.49M-5.76M
Market Cap 1.61B
Price to Earnings Ratio -18.03
Price to Sales Ratio 3.56
Price to Cash Ratio 15.31
Price to Book Ratio -3.37
Dividend Yield -

Share Statistics

Shares Outstanding 208.96M
Average Volume (1 week) 4.99M
Average Volume (1 Month) 4.2M
52 Week Change 46.48%
52 Week High 9.50
52 Week Low 4.03
Spread (Intraday) 0.27 (3.47%)

Company Info

Company Name BioCryst Pharmaceuticals Inc
Address 2711 centerville road
wilmington, delaware 19808
Website https://www.biocryst.com
Industry biological pds,ex diagnstics (2836)